HYDREA Medical Abbreviation

Hydroxyurea

Hydroxyurea, commonly known by its abbreviation HYDREA, is a medication used primarily in the treatment of certain types of cancer, including chronic myelogenous leukemia and squamous cell carcinoma of the head and neck. It works by slowing the growth of cancer cells in the body, thereby helping to control the disease. Hydroxyurea is also used to reduce the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia. Its mechanism involves interfering with the synthesis of DNA, which is crucial for the replication of rapidly dividing cells.

Despite its benefits, Hydroxyurea can cause side effects such as lowered blood cell counts, which may increase the risk of infections or bleeding. Patients undergoing treatment with this medication require regular monitoring by healthcare professionals to manage these potential adverse effects effectively. The drug's ability to modify the course of certain diseases makes it a valuable tool in medical oncology and hematology, offering hope and improved quality of life for many patients.